Brahmer JR - Search Results

1

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, Chow LQ, Vokes EE, Felip E, Holgado E, Barlesi F, Kohlhäufl M, Arrieta O, Burgio MA, Fayette J, Lena H, Poddubskaya E, Gerber DE, Gettinger SN, Rudin CM, Rizvi N, Crinò L, Blumenschein GR Jr, Antonia SJ, Dorange C, Harbison CT, Graf Finckenstein F, Brahmer JR. Borghaei H, et al. Among authors: brahmer jr. N Engl J Med. 2015 Oct 22;373(17):1627-39. doi: 10.1056/NEJMoa1507643. Epub 2015 Sep 27. N Engl J Med. 2015. PMID: 26412456 Free PMC article. Clinical Trial.

2

Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questions.

Lin TL, Brahmer JR. Lin TL, et al. Among authors: brahmer jr. Curr Oncol Rep. 2004 Jul;6(4):251-8. doi: 10.1007/s11912-004-0032-3. Curr Oncol Rep. 2004. PMID: 15161575 Review.

3

Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.

Brock MV, Hooker CM, Syphard JE, Westra W, Xu L, Alberg AJ, Mason D, Baylin SB, Herman JG, Yung RC, Brahmer J, Rudin CM, Ettinger DS, Yang SC. Brock MV, et al. J Thorac Cardiovasc Surg. 2005 Jan;129(1):64-72. doi: 10.1016/j.jtcvs.2004.08.022. J Thorac Cardiovasc Surg. 2005. PMID: 15632826 Free article.

4

Adjuvant therapy for resected non-small-cell lung cancer: past, present, and future.

Juergens RA, Brahmer JR. Juergens RA, et al. Among authors: brahmer jr. Curr Oncol Rep. 2005 Jul;7(4):248-54. doi: 10.1007/s11912-005-0046-5. Curr Oncol Rep. 2005. PMID: 15946582 Review.

5

Adjuvant treatment in non-small cell lung cancer: Where are we now?

Juergens RA, Brahmer JR. Juergens RA, et al. Among authors: brahmer jr. J Natl Compr Canc Netw. 2006 Jul;4(6):595-600. doi: 10.6004/jnccn.2006.0049. J Natl Compr Canc Netw. 2006. PMID: 16813727 Review.

6

Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.

Juergens R, Brahmer J, Ettinger D. Juergens R, et al. Cancer Chemother Pharmacol. 2007 Apr;59(5):621-9. doi: 10.1007/s00280-006-0304-8. Epub 2006 Aug 26. Cancer Chemother Pharmacol. 2007. PMID: 16937106 Clinical Trial.

7

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Sandler A, et al. N Engl J Med. 2006 Dec 14;355(24):2542-50. doi: 10.1056/NEJMoa061884. N Engl J Med. 2006. PMID: 17167137 Free article. Clinical Trial.

8

Second-line Therapy for advanced non-small-cell lung cancer.

Hann CL, Brahmer JR. Hann CL, et al. Among authors: brahmer jr. Curr Oncol Rep. 2006 Jul;8(4):243-7. doi: 10.1007/s11912-006-0027-3. Curr Oncol Rep. 2006. PMID: 17254522 Review.

9

Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.

Brahmer JR, Ettinger DS. Brahmer JR, et al. Respirology. 2007 May;12(3):320-5. doi: 10.1111/j.1440-1843.2007.01081.x. Respirology. 2007. PMID: 17539833 Review.

10

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

Taguchi F, Solomon B, Gregorc V, Roder H, Gray R, Kasahara K, Nishio M, Brahmer J, Spreafico A, Ludovini V, Massion PP, Dziadziuszko R, Schiller J, Grigorieva J, Tsypin M, Hunsucker SW, Caprioli R, Duncan MW, Hirsch FR, Bunn PA Jr, Carbone DP. Taguchi F, et al. Among authors: brahmer j. J Natl Cancer Inst. 2007 Jun 6;99(11):838-46. doi: 10.1093/jnci/djk195. J Natl Cancer Inst. 2007. PMID: 17551144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page